Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection.
about
Data Standardization and Quality Management.The High Cost of Stroke and Stroke Cytoprotection Research.Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C.Stroke Cytoprotection: Can Repeating History with New Expectations Really Be the Path to Success in Stroke Research?Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.
P2860
Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Selecting Patients for Intra-A ...... cal Trial for Neuroprotection.
@ast
Selecting Patients for Intra-A ...... cal Trial for Neuroprotection.
@en
type
label
Selecting Patients for Intra-A ...... cal Trial for Neuroprotection.
@ast
Selecting Patients for Intra-A ...... cal Trial for Neuroprotection.
@en
altLabel
Selecting Patients for Intra-A ...... ical Trial for Neuroprotection
@en
prefLabel
Selecting Patients for Intra-A ...... cal Trial for Neuroprotection.
@ast
Selecting Patients for Intra-A ...... cal Trial for Neuroprotection.
@en
P2093
P2860
P921
P1433
P1476
Selecting Patients for Intra-A ...... cal Trial for Neuroprotection.
@en
P2093
Chris Coffey
E Clarke Haley
Elizabeth McNeil
Howard Levy
Jeff Saver
Kent Pryor
Lawrence Wechsler
Marc Fisher
Marilyn Rymer
Patrick Lyden
P2860
P304
P356
10.1161/STROKEAHA.116.013881
P407
P577
2016-11-01T00:00:00Z